#IP powers the success of America’s #biopharma industry. Ahead of #WorldIPDay, let's revisit 10 reasons why our Executive Director, Dan Leonard, says innovation needs it: weworkforhealth.org/post/10-reason…

During #WorldIPDay, it's crucial to highlight the need for the #EPICAct to protect investment in small molecule drug development— and ensure patients continue to benefit from innovation. Learn more from We Work For Health: weworkforhealth.org/post/ira-three…

.Deborah Ross just helped to push HR 842 over the top, it’s now the most supported health care bill in the House this Congress. Let’s pass the #MCED Act and deliver early cancer screenings to seniors!

With Richard Hudson’s leadership, HR 842 has crossed a critical threshold – majority support in the House! Making it the most popular health care bill in the House. Let’s pass the #MCED Act and expand access to early cancer detection for seniors!

Thank you Senator Thom Tillis for sponsoring the #EPICAct and leveling the innovation playing field, and ending the #PillPenalty NCLifeSci alanwinsteadnc

Major Economic Development Announcement 📢 Genentech, a member of the Roche Group based in Switzerland has announced plans to invest $700 million in #HollySprings to establish a new high-volume fill/finish manufacturing facility. Read more ➡️ bit.ly/3YClSWr

Instituting #PriceControls from foreign, government-run healthcare systems will not solve anything. Instead, MFN will deplete #biopharma innovation. Read more on why we oppose MFN to support innovation and U.S. jobs: weworkforhealth.org/post/wwfh-stat…

Lowering the cost of drugs while preserving innovation requires policing the bad actors in the U.S. health care system. MFN does not do this, but instead introduces mismatched #PriceControls that will stifle innovation. Learn more from @weworkforhealh: weworkforhealth.org/post/wwfh-stat…

🧬Senator Thom Tillis must stand with North Carolinians and ensure biopharmaceutical companies can continue to bring lifesaving treatments to patients and support local jobs. It is time to reject unworkable price-setting policies like #MostFavoredNation. bit.ly/3GBNDZ9

NEW! Laura Gunter applauds Senator Thom Tillis Richard Burr Congressman Don Davis Rep. Richard Hudson Congressman Greg Murphy, M.D. for introducing the #EPIC Act in a Carolina Journal opinion. Learn how Congress can act now to protect patient access to life-changing innovations: bit.ly/4kGbR38

Pleased to see #OBBBA rejected #MFN #Rx price controls. Patients deserve a real solution, not barriers to care and misguided policies that don't address international freeloading or lower costs. Senator Thom Tillis Senator Ted Budd, continue to reject #MFN bit.ly/44bV6Yb

#NC is CNBC's 2025 top state for business! Our thriving life sciences industry contributes 100k+ local jobs, $41 billion to our state’s GDP. Lawmakers must prioritize policies to protect our business environment! bit.ly/3Ty3Rpq #NCPol NCGOP NC Democratic Party

NC's universities have generated $1.9T in GDP and 18K startups since 1980. But China just surpassed the U.S. in clinical trials for the first time. Now isn't the time to cut —it's time to double down on innovation. #Innovation #NCPol ncpoliticalnews.com/news/op-ed-now…

#News: Today, we announced plans to invest $2 billion in our existing manufacturing footprint in North Carolina’s Research Triangle Park site to support our late-stage pipeline. Learn more about this news here: bit.ly/44E6c8y

Today we broke ground on our new $700M facility in Holly Springs, NC—Genentech’s first East Coast site. This 700K-sq-ft hub will support next-gen metabolic medicines and create 1,900+ jobs, strengthening U.S. innovation in biotech. gene.com/media/press-re…

More than half of new FDA-approved drugs come from startups that depend on venture capital. #MFN pricing would choke off this funding pipeline and cause investment to dry up. realclearhealth.com/articles/2025/…

According to Scott Gottlieb, MD 🇺🇸: one of the best ways to preserve America's global edge is by boosting domestic innovation. Op-ed in The Washington Post: washingtonpost.com/opinions/2025/…

FUJIFILM Biotechnologies announces the opening of our Holly Springs, NC site, one of the largest commercial-scale cell culture biomanufacturing facilities in North America. Read more about this innovative new site here: fujifilmbiotechnologies.fujifilm.com/about/news/ope… #CDMO #Biologics #Biopharma

The case for PBM reform as made by the former CEO of the national PBM association

President Trump's recently announced tariffs in pharmaceuticals reduce access to meds, raise drug prices and will smother the small and midsized drug companies responsible for so much innovation. nclifesci.org/blog/pharma-ta…